Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Congruence Therapeutics Logo
Congruence Therapeutics Growth Score
86
CB Rank
18036
Heat Score
26
Congruence Therapeutics operates as a biotechnology company.
Founded
obfuscation
PrivateVenture - Series Unknown Montréal, Quebec, Canada11-50 congruencetx.com/
Biotechnology
Medical
Overview

Congruence Therapeutics
Total Funding
obfuscation
Growth Score
86
Heat Score
26

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score86
-11 pts
in past quarter
Heat Score 26
-67 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Congruence Therapeutics

CB Rank
18036
Congruence Therapeutics operates as a biotechnology company.
Founded
obfuscation
PrivateVenture - Series Unknown Montréal, Quebec, Canada11-50 congruencetx.com/
Biotechnology
Medical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Congruence Therapeutics Inc.
Operating Status Active
Company Type For Profit
About the Company
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
Predictions & Insights

Growth Insight

See this Growth Insight
Congruence Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Revenir™ Product Engine
A computational drug discovery engine that models protein dynamics to identify and predict small molecule stabilizers for disease correction.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown
obfuscation
Venture Round - Congruence Therapeutics Logo
Venture Round - Congruence Therapeutics
9
obfuscation
Dimension Capital, OrbiMedVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Board Members and Advisors 1 Contacts 21

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

699
-40.1%
 in past month

IT Spend

$733.8KThis year, Congruence Therapeutics is projected to spend $733.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Financial Services Logo
Financial Services
81

Active Website Tech Count

19Congruence Therapeutics is actively using 19 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Apple Mobile Web Clips Icon.

Total IP

10The intellectual property of Congruence Therapeutics includes 4 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Congruence Therapeutics has registered 6 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Congruence Therapeutics's headquarters? Congruence Therapeutics is located in Montréal, Quebec, Canada.Who invested in Congruence Therapeutics? Congruence Therapeutics has 13 investors including SilverArc Capital and  Investissement Quebec.When was the last funding round for Congruence Therapeutics? Congruence Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Congruence Therapeutics's competitors? Alternatives and possible competitors to Congruence Therapeutics may include Cradle, MapLight Therapeutics, and  Juvena Therapeutics.How much funding has Congruence Therapeutics raised to date? Congruence Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|